Loxacor-d4(78302-26-8)
- Name: Loxacor-d4
- Synonyms:2-[1-(2,6-Dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole-d4;Ba-168-d4;Britlofex-d4;Lofetensin-d4;Lofexidine-d4;Loxacor-d4;MDL-14042A-d4
- Molecular Formula:C11H8D4Cl2N2O
- Molecular Weight:0
- CAS Registry Number:78302-26-8
- EINECS:
- Melting Point:229-231?C
- Water Solubility:
CAS No.78302-26-8 Lofexidine-d4 Hydrochloride
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.78302-26-8 Lofexidine-d4
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.78302-26-8 Lofexidine-[d4]
Assay:95% Appearance:Off-White Solid Application:伪2-Adrenoceptor agonist related structurally to Clonidine. Used in treatment of opioid withdrawal symptoms; antihypertensive.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 776270-75-8/Methanone, (5-methyl-4-isoxazolyl)[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]-
- 776270-44-1/2,5-Pyridinediamine,3,4,5,6-tetrahydro-4-methyl-,(4R,5S)-rel-(9CI)
- 776269-51-3/2-m-tolylpiperazine
- 776269-45-5/Imidazo[4,5-d]imidazol-2-amine, 1,3a,4,5,6,6a-hexahydro-, cis- (9CI)
- 776265-97-5/Hydrazinecarboximidamide, N-ethyl-N,N-dimethyl- (9CI)
- 776265-88-4/1-Pyrrolidinemethanesulfonicacid(9CI)
- 78304-53-7/1H-Indole, 5-phenoxy-
- 776264-55-2/1-Aza-4-silacyclohexane,1,4,4-trimethyl-(9CI)
- 78303-54-5/6(R),7-ISOPROPYLIDENE-HEPTANOL
- 73528-95-7/2-Butenamide, 3-hydroxy-N,N-dimethyl- (9CI)
- 776263-63-9/Pyrrolidine, 2-(1-methylethyl)-2-(2-propenyl)-, (R)- (9CI)
- 776262-03-4/Pyrrolo[1,2-a]pyrazin-7-ol, octahydro-2-methyl-, (7R-cis)- (9CI)
- 78303-19-2/S-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-oxododecanethioate
- 776258-36-7/Methanesulfonamide, N-[4-[[(6-hydroxy-4,5,7-trimethyl-2-benzothiazolyl)amino]methyl]phenyl]-
- 776257-58-0/4(1H)-Quinazolinone, 5,8-dihydroxy-2-methyl- (9CI)
- 78302-26-8/Loxacor-d4
- 776255-60-8/2H-Pyran-2-carboxylic acid, tetrahydro-2-hydroxy- (9CI)
- 776254-83-2/2-Naphthalenecarboximidamide,N,6,7-trihydroxy-3,4-dihydro-
- 776253-96-4/Carbamimidothioic acid, 1-methyl-1H-indol-3-yl ester (9CI)
- 776253-44-2/2H-1-Benzopyran-6-amine,2,2,5,8-tetramethyl-(9CI)
- 776251-95-7/Spiro[1,3-dioxolane-2,3-[7]oxabicyclo[4.1.0]heptane]-6-carboxylic acid, 2-methyl-, (1alpha,2alpha,6alpha)- (9CI)
- 776250-31-8/Benzenamine, 2-methoxy-4-nitro-N-nitroso- (9CI)
- 776250-13-6/1H-Imidazo[4,5-c]pyridine,4,5,6,7-tetrahydro-1,2-dimethyl-(9CI)
- 776249-60-6/Ethanesulfonic acid, 2-(cyanomethylamino)- (9CI)
- 776247-24-6/2H-1-Benzopyran-4-methanamine,3,4-dihydro-6-methoxy-(9CI)
- 776246-72-1/4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-ethyl-6-hydroxy-7-oxo-, trans- (9CI)
- 73523-46-3/4,8-Methano-1,3-dioxolo[4,5-e][1,3]oxazepine (9CI)
- 776245-72-8/1-Propanone,3-(dimethylamino)-1-(2-fluoro-5-methylphenyl)-(9CI)
- 776243-57-3/2-Oxazolemethanamine,N,4-dimethyl-5-phenyl-(9CI)
- 776239-97-5/L-glycero-L-galacto-Heptitol, 2,6-anhydro-7-deoxy-7-(dimethylamino)- (9CI)